Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data & AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2017 / Aug / When Minutes Matter
Clinical Omics Genomics & DNA Analysis

When Minutes Matter

New tests can speed up the diagnosis of severe sepsis, ensuring patients get the right treatment before it’s too late

By Michael Schubert 08/11/2017 1 min read

Share

Sepsis is one of the most time-critical diagnoses a hospital can make. In the most severe cases, it’s estimated that patients’ likelihood of survival decreases by 7.6 percent each hour that passes without effective treatment (1). But with common symptoms like fever and pain, it can be difficult to conclusively identify sepsis in a timely manner.

The lab-on-a-chip system that uses a patient’s immune response to diagnose sepsis.Credit: Janet Sinn-Hanlon

Fortunately, science is on the case. Two groups of researchers have recently published tests that promise rapid, reliable diagnosis of sepsis: one, a new PCR-based method, and two, a portable lab-on-a-chip device. The first, a TaqMan-based multiplex real-time PCR detection system, probes conserved regions of the 16S rDNA gene in 10 common bacterial pathogens (2). It not only detects the organisms causing sepsis, but also positively identifies them in a matter of hours, ensuring that patients can receive appropriate antibiotic treatment as soon as possible – and freeing doctors from the need to wait a day or more for blood cultures to provide the same information.

The second test takes a unique approach – instead of looking for the cause of infection, it detects the patient’s immune response (3). How? The device takes a complete white blood cell count, a neutrophil count, and measures levels of the CD64 neutrophil cell surface marker. As the immune response increases, so do these numbers, giving doctors a rapid heads-up that the patient’s condition is deteriorating. In some cases, the immune response can spot sepsis even before the causative pathogen is detectable in the blood. “We think we need both approaches,” said Rashid Bashir, senior author on the latter study. “Detect the pathogen, but also monitor the immune response. (4)”

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. “New test to rapidly diagnose sepsis”, (2017). Available at: http://bit.ly/2uaocaU. Accessed August 4, 2017. CF Liu et al., “Rapid diagnosis of sepsis with TaqMan-based multiplex real-time PCR”, J Clin Lab Anal, [Epub ahead of print] (2017). PMID: 28512861. U Hassan et al., “A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification”, Nat Commun, 8, 15949 (2017). PMID: 28671185. L Ahlberg, “Quick test finds signs of sepsis in a single drop of blood”, (2017). Available at: http://bit.ly/2vwc8Ai. Accessed August 4, 2017.

About the Author(s)

Michael Schubert

While obtaining degrees in biology from the University of Alberta and biochemistry from Penn State College of Medicine, I worked as a freelance science and medical writer. I was able to hone my skills in research, presentation and scientific writing by assembling grants and journal articles, speaking at international conferences, and consulting on topics ranging from medical education to comic book science.

More Articles by Michael Schubert

False

Advertisement

Recommended

False

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.